Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN)’s share price traded down 3.3% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The firm has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The firm’s 50 day moving average is GBX 3.87 and its 200-day moving average is GBX 3.95. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Buying and Selling at Eden Research

In related news, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.